Sharepoint Solutions
PRODUCTS
-
Mikart’s analytical services begin with accurate measurements of formulation characteristics and are informed by our dedicated team’s mastery of process — the precise changes that maximize your product’s performance and market adoption.
-
Automate data collection, maximize resource utilization, and increase trial capacity.
-
Single-use, automated filtration system designed to deliver robust process control during the clarification/harvest step.
-
Our goal is to help your business succeed by working with you to streamline the FDA regulatory process. ProPharma’s team of science- based regulatory consultants commands an unparalleled breadth and depth of knowledge pertaining to FDA’s regulatory framework and can work with you to accomplish your business objectives.
-
Shorten start-up times for your clinical research studies by eliminating manual spreadsheets once and for all. SuiteSuccess for contract and clinical research organizations (CROs) allows you to unify clinical applications to improve visibility and oversight across the organization in one software platform. Now you can automate inefficient manual processes, from bid to bill, and deliver more quickly and more profitably than your competitors.
WHITE PAPERS AND CASE STUDIES
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
-
Expert Consulting And MRCT Strategy Rescues Oncology Program
Uncover how this strategic approach yielded significant outcomes, including uncovering missing data through IB review, streamlining dosing timelines, and achieving successful recruitment milestones.
-
Comprehensive Pathway To Seamless Scale-Up Of mRNA DP Manufacturing
An integrated approach to mRNA drug product manufacturing helps to accelerate drug development, mitigate risks, and ultimately deliver life-changing therapies to patients.
-
Richter BioLogics Drives Efficiency And Compliance With Unified Quality
Learn how one CDMO tripled production, improved audit readiness, and built customer trust by unifying quality systems and embracing a digital-first approach.
-
GSK And Medable Discuss The Next Phase Of DCTs
GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
-
The Effect Of Conventional Cooling Versus Controlled Ice Nucleation On Primary Drying Time
See how controlled ice nucleation shortens lyophilization cycles, supports higher drying temperatures, and reduces complexity for amorphous and mixed formulations without sacrificing quality.
-
Pioneering The End-To-End Decentralized Trial Experience
This collaboration highlights the potential of decentralized clinical trials (DCTs) to transform trial execution, as well as offering a replicable model for future research.
-
FDA's Regenerative Medicine Advanced Therapy (RMAT) Program
RMAT qualification requires preliminary clinical evidence demonstrating the potential to address an unmet medical need. This designation grants benefits like intensive guidance and faster FDA review.
-
Case Study: Recruiting Pediatric Ultra-Rare Disease Patients
Explore how Rezolute was able to overcome challenges while recruiting pediatric patients for a Congenital Hyperinsulinism (HI) clinical trial using a streamlined, single-source tool.
-
Authentic Engagement: Reaching Underserved Lupus Patients
By partnering with the ICLF, see how we were able to gain access to and build trust with influential community leaders and advocates within the African American communities located near study sites.
-
A Solid Solution And Impeccable Service Wins Over This Client
In this case study, learn why Canada's oldest cheese company looked to Newterra for systems and support.
-
Outgrowing Excel: Implementing RTSM Software In A Live Phase I Trial
Moving from manual spreadsheets to RTSM mid-study requires precision. Learn how clinical teams maintain trial momentum while executing protocol changes without delays.
NEWS
-
Researchers Warn Of Risks Posed By 'Contaminants Of Emerging Concern' Found In Crops, Agricultural Soil3/31/2026
A new international study offers insights into the health risks posed by crops’ absorption of “contaminants of emerging concern” (CECs) and flags knowledge gaps the authors say must be addressed.
-
Axim Biotechnologies Files Pre-Submission With FDA For CLIA Waiver Pathway On Lactoferrin Point-Of-Care Diagnostic Test6/24/2025
Axim Biotechnologies, Inc. a leading developer of rapid diagnostic testing for ocular and systemic conditions, today announced that it has filed a Pre-Submission (Pre-Sub Q) with the U.S. Food and Drug Administration (FDA) as the first formal step in seeking a Clinical Laboratory Improvement Amendments (CLIA) Waiver for its rapid, point-of-care Lactoferrin diagnostic test (TearScan Lf).
-
EPA Awards $1,687,013,000 To Florida For Water Infrastructure Resiliency3/25/2026
The U.S. Environmental Protection Agency (EPA) has awarded $1,687,013,000 in supplemental appropriation funds to Florida to improve water infrastructure resiliency in the aftermath of Hurricanes Helene and Milton.
-
PolyPeptide Strengthens Global Peptide Production With Modular Facility Design Approach9/24/2025
PolyPeptide Group AG (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful delivery and installation of pre-built modules at its Malmö, Sweden facility. This marks a key milestone in the company’s modular expansion project at the site, which aims to double its solid-phase peptide synthesis (SPPS) capacity.
-
New Research To Unlock Smart Sewer Potential For Water Utilities8/20/2025
A groundbreaking research initiative led by a multidisciplinary team of engineers and utilities has been launched to address the critical need for industry-wide guidance on smart sewer system implementation.